We determined whether the implantation of human pancreatic cancer cells into the pancreas of nude mice can be used to select variants with increasing metastatic potential. COLO 357 line fast-growing cells were injected into the spleen or pancreas of nude mice. Hepatic metastases were harvested, and tumor cells were reinjected into the spleen or pancreas. This cycle was ( repeated several times to yield cell lines L3.6sl spleen ) ( ) to liver and L3.6pl pancreas to liver . The variant cells produced significantly higher incidence and number of lymph node and liver metastases than the parental cells. Their increased metastatic potential was associ-( ) ated with increased expression mRNA and protein of the proangiogenic molecules basic fibroblast growth factor, vascular endothelial growth factor, and interleukin-8. The metastatic cells also exhibited increased motility and invasiveness, which were associated with ( ) increased expression of collagenase type IV MMP-9 and decreased expression of E-cadherin. Collectively, the data show that the orthotopic implantation of human pancreatic cancer cells in nude mice is a relevant model with which to study the biology of pancreatic cancer metastasis and to select variant cell lines with enhanced metastatic potential.
Introduction
Cancer of the exocrine pancreas is a major unsolved health problem with approximately 27,000 deaths per year in the United States and 50,000 deaths per year in Western Eu-[ ] rope 1,2 . It is characterized by extensive local invasion as well as early lymphatic and hematogenous metastasis. Due to the inability to detect pancreatic cancer at an early stage, its aggressiveness, and the lack of effective systemic therapies, only 1% to 4% of all patients with adenocarcinoma of [ ] the pancreas will be alive 5 years after diagnosis 3 -6 . Because most deaths from pancreatic cancer are caused by metastasis, improvements in treatment require a better understanding of the biology of this process.
The process of metastasis consists of sequential and selective steps that include proliferation, induction of angiogenesis, detachment, motility, invasion into the circulation, aggregation and survival in the circulation, cell arrest in distant capillary beds and extravasation into the organ parenchyma, response to local growth factors, induction of [ ] angiogenesis, and proliferation 7 . The outcome of metastasis is determined by multiple interactions between metastatic [ ] tumor cells and host factors 7,8 . To produce clinically relevant metastases, tumor cells must complete all steps in [ ] the metastatic cascade 7 . Thus, the failure to produce a metastasis can be due to different single or multiple defi-[ ] ciencies 9 .
The process of metastasis is highly selective and its outcome depends on the interaction of metastatic cells that preexist within a heterogeneous primary neoplasm and a [ ] variety of host factors 7,8 . Critical to our studies has been the development of relevant in vivo models for cancer [ ] metastasis 10,11 , which have produced conclusive evidence that the outcome of metastasis is regulated by the interaction of unique tumor cells with homeostatic mecha-[ ] nisms 7,8 . Indeed, studies from our laboratory and others have shown that malignant human tumors implanted into orthotopic organs are highly vascularized, grow progressively, and produce distant metastasis, whereas the implantation of the same tumors at an ectopic organ does not lead [ to extensive angiogenesis or production of metastasis 12 -] ( 20 . Similarly, the isolation of multiple variants from biologi-) cally heterogeneous neoplasms that differ in metastatic properties has greatly advanced our understanding of the genetic and epigenetic determinants of cancer metastasis [ ] 7-9 .
Two general methods have been used to select metastatic variants in vivo. In the first, tumor cells are implanted into orthotopic organs, and spontaneous metastases from distant organs are isolated and reinjected into orthotopic or-gans. In the second method, tumor cells are introduced into the circulation to produce lesions in distant organs, or experimental metastases. Spontaneous metastases then occur subsequent to completion of all steps of the metastatic process, whereas experimental metastases reflect the ability of tumor cells to survive in the circulation, arrest in a distant capillary bed, and grow in a distant organ paren-[ ] chyma 7 -11 .
Unfortunately, such models do not exist for pancreatic cancer. The purpose of the present study was, therefore, to develop an orthotopic model for metastasis of human pan-( ) creatic cancer, to select in vivo variant lines with increasing metastatic capacity, and to begin detailed characterization of their properties. To do so, we used the COLO 375 human pancreatic cancer cell line originally established by [ ] Morgan et al. 21 from a celiac axis lymph node that had been partially replaced by neoplastic foci of well-differentiated, mucin-containing pancreatic ducts. Vezeridis et al.
( ) subsequently injected the fast-growing FG variant line of the COLO 375 cells into the spleen of nude mice. The in vivo isolated cells designated as L3.3 produced liver lesions [ ] at a higher incidence than the original COLO 375 cells 22 .
In the present study, we show that orthotopic implantation of heterogeneous human pancreatic adenocarcinoma into nude mice results in rapid growth and production of lymph node and liver metastases. Cells isolated from the metastases were more metastatic because they expressed several genes that correlate with production of metastasis.
Materials and Methods

Animals
( ) Male athymic nude mice BALB/ c background were purchased from the Animal Production Area of the National Cancer Institute-Frederick Cancer Research and Develop-( ) ment Center Frederick, MD . The mice were housed and maintained in laminar flow cabinets under specific pathogen-free conditions in facilities approved by the American Association for Accreditation of Laboratory Animal Care and in accordance with current regulations and standards of the US Department of Agriculture, US Department of Health and Human Services, and the National Institutes of Health. The mice were used in accordance with institutional guidelines when they were 8 to 12 weeks old.
Pancreatic Cancer Cell Lines and Culture Conditions
[ ] The FG and L3.3 21,22 human pancreatic cancer cell lines were maintained as monolayer cultures in Dulbecco's ( ) minimal essential medium DMEM , supplemented with 10% ( ) fetal bovine serum FBS , sodium pyruvate, nonessential ( amino acids, L-glutamine, and a 2-fold vitamin solution Life ) Technologies, Rockville, MD . The cultures were incubated at 378C in a mixture of 5% carbon dioxide and 95% oxygen. The cultures were tested and found to be free of Mycoplasma and the following pathogenic murine viruses: reovirus type 3, pneumonia virus, K virus, Theiler's encephalitis virus, Sendai virus, minute virus, mouse adenovirus, mouse hepatitis virus, lymphocytic choriomeningitis virus, ( ectromelia virus, and lactate dehydrogenase virus assayed ) by M. A. Bioproducts, Walkersville, MD . The cultures were maintained for no longer than 12 weeks after recovery from frozen stocks.
Tumor Cell Injection Techniques
For in vivo injection, cells were harvested from culture flasks by a 2 to 3 minutes treatment with trypsin and were transferred to serum-free Hanks' balanced salt solution ( ) HBSS . Only single-cell suspensions of greater than 90% ( ) viability trypan blue exclusion were used for injection.
Orthotopic injection Male nude mice were anesthetized with methoxyflurane. A small left abdominal flank incision was ( 6 made and the spleen exteriorized. Tumor cells 1 = 10 / 40 ) mL HBSS were injected subcapsularly in a region of the pancreas just beneath the spleen. We used a 30-gauge needle, a 1-mL disposable syringe, and a calibrated, pushbutton-controlled dispensing device to inject the tumor cell ( ) suspension Hamilton Syringe Co, Reno, NV . A successful subcapsular intrapancreatic injection of tumor cells was identified by the appearance of a fluid bleb without intraperitoneal leakage. To prevent such leakage, a cotton swab was held for 1 minute over the site of injection. One layer of ( the abdominal wound was closed with wound clips Auto-) clip; Clay Adams, Parsippany, NJ . The animals tolerated the surgical procedure well, and no anesthesia-related deaths occurred.
Intrasplenic inoculation Tumor cells were injected into the [ ] spleen by methods previously described in detail 11,12 . Briefly, mice were anesthetized with methoxyflurane, a small left abdominal flank incision was created, and the spleen ( 6 ) was exteriorized. Tumor cells 1 = 10 / 40 mL HBSS were injected into the spleen with a 30-gauge needle. The spleen was returned to the abdomen, and the wound was closed in one layer with wound clips. 
Immunohistochemistry
Paraffin-embedded tissues were sectioned at 4 to 6 mm thickness, mounted on positively charged Superfrost slides ( ) Fisher Scientific Co, Houston, TX , and allowed to dry overnight at room temperature. Sections were deparaffinized in xylene followed by a graded series of ethanol ( ) 100%, 95%, 80% , and rehydrated in phosphate-buffered ) solution, pH 7.5 . Paraffin-embedded tissues were used for localization of vascular endothelial growth factor/ vascular ( ) permeability factor VEGF/ VPF , basic fibroblast growth fac-( ) ( ) tor bFGF , matrix metalloproteinase-9 MMP-9 , and prolif-( ) erating cell nuclear antigen PCNA proteins. Sections analyzed for PCNA and MMP-9 were microwaved 5 minutes for [ ] antigen retrieval 23 . All other paraffin-embedded tissues ( were treated for 5 minutes with pepsin Biomeda, Foster ) City, CA at 378C and then washed 3 times with PBS. To [ ] identify CD-31/ PECAM-1 24 , frozen tissues were sec-( ) tioned 8 -10 mm , mounted on positively charged Plus ( ) slides Fisher Scientific , and air-dried 30 minutes. Frozen ( ) tissues were fixed in cold acetone 5 min , acetone/ ( ) ( ) chloroform 1:1 5 min , and acetone 5 min and washed 3 times with PBS.
After the specific pretreatment procedures, all samples were incubated with a 3% H O in methanol solution for 12 2 2 minutes at room temperature to block endogenous peroxidases. Sections were then washed 3 times with PBS and then incubated for 20 minutes at room temperature in a protein-blocking solution consisting of PBS supplemented with 1% normal goat serum and 5% normal horse serum. The primary antibodies were diluted in protein blocking solution to the desired concentration and applied to the sections overnight at 48C. The sections were then rinsed in PBS and incubated for 10 minutes in protein-blocking solution before the addition of peroxidase-conjugated secondary antibody. After incubation in secondary antibody for 1 hour at room temperature, the samples were washed and incu-( bated with stable diaminobenzidine DAB, Research Genet-) ics, Huntsville, AL . Staining was monitored under a brightfield microscope, and the reaction was stopped by washing with distilled water. Sections were counterstained with Gill's A positive reaction in this assay stained red. Control for endogenous alkaline phosphatase included treatment of the samples in the absence of the biotinylated probe and use of chromogen in the absence of any oligonucleotide probes. To check the specificity of the hybridization signal, ) the following controls were used: 1 RNase pretreatment of ) ) tissue sections; 2 a biotin-labeled sense probe; and 3
[ ] competition assay with unlabeled antisense probe 37 . A markedly decreased or absent signal was obtained after all of these treatments.
Stained sections were examined under a Zeiss photo-( ) microscope Zeiss equipped with a 3-chip-charged coupled ( ) device color camera model DXC-960 MD, Sony . The images were analyzed by using the Optimas Image Analysis ( ) software version 5.2, Bothell, WA . The samples were not counterstained, so the OD was due solely to the product of the ISH reaction. For each section, we determined the OD in several 2 = 2 mm zones located at the center and periphery of the tumor. Three to five different fields in each 2 = 2 mm zone were quantified to derive an average value. The intensity of staining was standardized to that of the inte-( ) grated OD of poly d T0
and determined by comparison 20 with the integrated OD of nonpathological pancreatic epithelial cells, which was set at 100.
In Vitro Growth Kinetics Pancreatic cancer cells were harvested from 75% confluent monolayer cultures by a brief trypsinization with 0.1% trypsin and 0.1% EDTA. The cells were washed in cold HBSS, plated at a density of 1500 cells per 38-mm 2 well, and then given supplemented DMEM containing 10% FBS. Cell growth was monitored after 8 hours and 1, 2, 3, and 4
[ ] days by using the MTT assay as described previously 38 . In vitro doubling times were calculated from the log phase [ ] growth curve 39 .
In Vitro Migration Assay
A modified Boyden chamber assay was used to examine the in vitro motility of the different pancreatic cancer cells.
( ) Polycarbonate filters pore size, 8 mm; diameter, 13 mm were glued to inserts, which were placed in the wells of 24-well tissue culture plates. The lower part of the chamber ( ) was filled with fibronectin 100 ng / mL as a chemo-( 4 ) attractant. Cells 2 = 10 were suspended in 100-ml HBSS and placed in the upper part of the chamber. After 6 hours incubation at 378C, the filters were carefully removed from the inserts, stained with hematoxylins losin for 10 minutes, and mounted on microscopic slides. The number of stained ( cells was counted in 10 microscopic fields each 0.161
2 ) mm at 100 = magnification. Migratory activity was quantified by the average number of cells per microscopic field.
Endothelial Cell Proliferation Assay ( ) Primary human umbilical vein endothelial cells HUVEC were cultured in complete DMEM containing 15% FBS and 10 ng / mL bFGF. Cell culture flasks were coated with 4 mg / mL gelatin. Cells were plated in 96-well plates at a density of 3 = 10 3 cells per well. After 24 hours, the supernatant in each well was removed, and 200 ml of conditioned medium of the different pancreatic cancer cells was added ( in various concentrations 10% and 50% conditioned ) medium . Conditioned medium was prepared by culturing 5 = 10 5 pancreatic cancer cells in a 6 well plate in supplemented DMEM containing 10% FBS for 5 days. After 4 days of incubation, the growth of HUVECs in various concentrated conditioned media of the different pancreatic cancer cells was monitored by MTT assay and compared to the growth of HUVECs treated with supplemented DMEM containing 15% FBS and 10 ng / mL bFGF only.
Statistical Analysis
The unpaired Student t test was used to compare the in vitro and in vivo results. Survival analysis was computed by the Kaplan-Meier method and compared by the log-rank 
Results
Selection of Highly Metastatic Variant Lines
In the first set of experiments, we injected cells from the FG line derived from COLO357 human pancreatic adeno-[ ] carcinoma cell line 21,22 into the spleen or pancreas of nude mice. Intrasplenic injection allows cells to reach the [ ] liver parenchyma within minutes after injection 13,14 . Liver colonization can occur rapidly and without necessity to overcome the barrier of the primary site microenvironment. The liver lesions thus formed are termed experimental metastases. In contrast, to produce liver lesions, human pancreatic cancer cells implanted into the pancreas must complete all the steps of the process. The lesions then are designated as spontaneous metastases. Experimental or spontaneous liver metastases were harvested, established in tissue culture, and designated as L3.4sl and L3.4pl, respectively. Cells harvested from these cultures were injected into the spleen or pancreas of another set of nude mice. Liver lesions were again isolated, and cells were established in culture. After three such selection cycles, ( lines L3.6sl and L3.6pl were established in culture Figure  ) 1 . Cytogenetic analysis confirmed the human origin of the cells.
To determine whether the isolated variants had increased metastatic potential, cells from the original FG line and from the L3.6sl, and L3.6pl lines were injected into the ( ) spleen and / or the pancreas of nude mice n s 20 . The mice were killed when moribund or by day 105 after injection. Tumorigenicity, production of metastases, and survival ( ) were determined Table 1 . In the first assay for experimental metastasis, we injected the cells into the spleen. In- ( ) experimental liver metastases in 10 of 19 mice P -.01 , and a median survival time of 71 days. For L3.6pl cells, 20 of 20 mice had spleen tumors and 13 of 20 had liver ( ) metastases P -.01 ; the median survival time was 34 days ( ) P -.01 . The highest median number of liver metastases ( ) was 10 3 -75 , found after intrasplenic injection of L3.6pl cells, suggesting that these cells have a higher capacity to colonize the liver.
In the second assay for spontaneous metastasis, we injected the cells into the pancreas. All three lines were ( ) 100% tumorigenic after intrapancreatic injection Table 1 . Liver metastases were produced in 1 of 20, 5 of 20, and 10 of 20 mice after injection of FG, L3.6sl, and L3.6pl cells, respectively. The median survival time was 84, 56, or 36 days after the intrapancreatic injection of FG, L3.6sl, and ( ) L3.6pl cells, respectively Figure 2 . These data show that selection of cells for experimental metastasis also increased their ability to form spontaneous metastasis. The selection of cells for spontaneous metastasis, however, yielded cells with the highest metastatic potential.
The intravenous IV injection of 1 = 10 FG cells produced a median of 75 experimental lung metastasis per ( ) mouse range, 18 -142 , whereas the intravenous injection of L3.6sl cells produced a median number of 3 lung lesions. The IV injection did not yield a significant number of liver metastases.
Cell Growth in Vitro and in Vivo
The in vitro doubling time of FG, L3.6sl and L3.6pl was 25, 20, and 16 hours, respectively. The average number of ( ) PCNAq cells per microscopic field in the pancreatic tumors agreed with the in vitro results. The average number of PCNAq cells per microscopic field was 178" 42, 289 " 48, and 399 " 33 in 72-to 84-day-old pancreatic tumors of FG, 53-to 59-day-old pancreatic tumors of L3.6sl, and 35-to 37-day-old pancreatic tumors produced by L3.6pl cells ( ) Figure 3 ; Table 2 .
Cell Motility
To determine whether the increased metastatic potential was associated with increased motility, we used a modified ( ) Boyden chamber assay with fibrinogen 100 ng / mL as a chemoattractant. The motility of L3.6sl and L3.6pl cells differed significantly from that of the FG cells. Specifically, the number of FG, L36sl, and L3.6pl cells per 10 microscopic fields was 3 " 1, 38 " 5, and 44 " 7 cells, respec-( ) tively P -.001 .
Relative Expression of MMP-2/ MMP-9 and E-cadherin Detachment of malignant cells from the primary tumor and penetration of host stroma including basement mem-( ) branes and extracellular matrix ECM is an essential part of [ ] the metastatic process 7 . The degradation of the ECM components surrounding malignant tumors is primarily me-[ ] diated by MMPs or type IV collagenases 41 -46 . To determine whether the metastatic potential of the variant cells correlated with their production of MMPs, we examined the expression of MMPs by ISH.
Pancreatic tumors derived from L3.6pl and L3.6sl cells had significantly higher MMP-9 and MMP-2 mRNA levels ( ) than tumors derived from FG Figure 4 , Table 3 . The MMP-9 mRNA expression level was significantly higher in ( pancreatic tumors derived from L3.6pl cells spontaneous ) ( ) metastasis than in L3.6sl cells experimental metastasis . The expression of E-cadherin, a transmembrane glycoprotein that is directly related to cell-to-cell cohesion, was high in tumors derived from FG and low in tumors derived from L3.6sl and L3.6pl cells. IHC staining of pancreatic tumors with anti-MMP-9 antibody revealed a significant increase in the expression of MMP-9 protein in tumors de-( rived from metastatic L3.6sl and L3.6pl cells Figure 3, ) Table 2 .
Gelatin zymography of tumor lysates revealed 5-fold and 3.5-fold increases in activity of the 92-kDa MMP-9 in pan-( ) creatic tumors or culture supernatants derived from L3.6sl and L3.6pl cells, respectively, as compared with FG cells. MMP-2 activity was indistinguishable among the 3 different tumors. Additionally, a 3-fold increase of MMP-9 activity was determined in lysates of pancreatic tumors from L3.6pl ( ) versus L3.6sl cells Figure 5 .
Expression of VEGF, bFGF, IL-8, and Quantification of Microvessel Density
In situ hybridization of tissue sections demonstrated a significant difference in VEGF/ VPF, bFGF, and IL-8 mRNA To determine whether the proangiogenic molecules produced by the pancreatic tumor cells were biologically active, we incubated HUVEC with culture supernatants of the three cell lines and determined HUVEC proliferation by the MTT [ ] assay 38,39 . Conditioned media of FG, L3.6sl, and L3.6pl ( ) cells stimulated proliferation of HUVECs P -.02 . To further investigate angiogenesis in the orthotopic tumors, we quantified MVD after staining frozen sections of tumors with CD31/ PECAM-1. In pancreatic tumors derived from FG, L3.6sl, and L3.6pl, the average number of CD31/ PECAM-1 ( 2 ) positive vessels per 1-mm field at 40= magnification ( ) was 3 " 1, 44 " 11, and 89 " 25, respectively P -.001 . The recovered cells were expanded in culture to repeat the process. After several cycles, the behavior of the cells was compared with that of the parental cells. The metastatic potential of the pancreatic cancer cells in nude mice was determined by two assays. The first involved the implantation of the cells into the pancreas and a count of spontaneous lymph nodes and liver metastasis. The second measured to ability of the pancreatic cancer cells to grow in the liver parenchyma ( subsequent to intrasplenic implantation experimental ) metastasis . In general, there was good agreement in the results of the two assays.
Discussion
Earlier data from our laboratory established that the implantation site of metastatic human tumor cells determines whether they will produce distant metastasis. Specifically, the growth of tumors in orthotopic organs facilitates production of metastasis, whereas growth in ectopic organs [ ] ments avoids the issue of neoplastic heterogeneity 53 and, thus, the orthotopic inoculation of human pancreatic cancer cell suspensions is mandatory for reproducible studies of the biology of pancreatic cancer metastasis. In this study, we undertook a series of intrapancreatic and intrasplenic implantation experiments with cell suspensions of a human pancreatic cancer cell line to select and isolate cell lines with higher tumorigenicity and increased metastatic potential. Intrasplenic and intrapancreatic implantation demonstrated a significant increase in the incidence of primary ( ) tumors pancreas, spleen and liver metastasis, as well as in median number of liver metastases for L3.6sl and L3.6pl cells over FG cells. Moreover, the incidence and median number of liver metastases were higher after either intrapancreatic or intrasplenic injection of L3.6pl as compared with L3.6sl cells, suggesting that the repeated pancreasto-liver selection procedure isolated cells with higher poten-[ ] tial for metastasis. More than a century ago, Paget 54 proposed that the outcome of metastasis depended on the interaction of specific tumor cells with a favorable organ environment. The present data support the 'seed and soil ' [ ] hypothesis 54 . After IV injection of the more heterogeneous FG cells, a significantly greater differential favoring lung over liver metastases was produced than after the IV injection of pancreatic cancer cells selected for their ability to produce liver metastases.
The The expression of angiogenic molecules differed significantly among the 3 pancreatic cell lines. Both in vitro cultured cells and in vivo tumors derived from L3.6pl and L3.6sl cells expressed higher levels of VEGF/ VPF, bFGF, IL-8, and MMP-9 than did the low metastatic FG cells or tumors. The increased expression level of the angiogenic molecules directly correlated with MVD of the tumor lesions as measured by immunostaining of endothelial cells with antibodies against CD31/ PECAM-1. Finally, the biological activity of the angiogenic molecules was proven by their ability to stimulate growth of HUVEC. In good agreement with the IHC data, the conditioned media of all 3 pancreatic tumor cell variants stimulated the growth of HUVECs; however, the conditioned media of L3.6sl and L3.6pl cells stimulated the growth of HUVECs significantly more than the conditioned medium of FG cells.
Increased levels of the epidermal growth factor receptor and its ligand, transforming growth factor, have been associated with increased malignancy of human bladder, breast, [ ] and colon cancers 85 -88 . The expression level for these genes, however, did not vary among the pancreatic cell lines. The c-met oncogene, which encodes the receptor for hepatocyte growth factor, has been shown to promote cell [ ] motility and invasiveness 89 -92 . We did not find discernible differences in expression of c-met among the three lines.
In summary, we report the development of a reproducible orthotopic model to study the biology of human pancreatic cancer metastasis. We also succeeded in isolating variant lines with enhanced metastatic properties as demonstrated by a battery of assays. 
